|
2021 Journal Article Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021Chang, Christina C., Blyth, Christopher C., Chen, Sharon C-A, Khanina, Anna, Morrissey, C Orla, Roberts, Jason A., Thursky, Karin A., Worth, Leon J. and Slavin, Monica A. (2021). Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021. Internal medicine journal, 51 (S7), 3-17. doi: 10.1111/imj.15585 |
|
2021 Journal Article 2021 adaptation of the editorial policy of Anaesthesia Critical Care and Pain Medicine (ACCPM)Lefrant, Jean-Yves, Pirracchio, Romain, Benhamou, Dan, Njeim, Rosanna, Ausset, Sylvain, Bastide, Sophie, Biais, Matthieu, Bouvet, Lionel, Brissaud, Olivier, Brull, Sorin J., Capdevila, Xavier, Cuvillon, Philippe, Dadure, Christophe, David, Jean-Stéphane, Bin, Du, Fischer, Marc-Olivier, Forget, Patrice, Fujii, Tomoko, Godier, Anne, Gopalan, Dean P., Hamada, Sophie, Joannes-Boyau, Olivier, Kerever, Sébastien, Kipnis, Éric, Kolodzie, Kerstin, Landau, Ruth, Le Gall, Arthur, Le Guen, Morgan, Legrand, Matthieu ... Bouaziz, Hervé (2021). 2021 adaptation of the editorial policy of Anaesthesia Critical Care and Pain Medicine (ACCPM). Anaesthesia, Critical Care and Pain Medicine, 40 (5) 100957, 1-5. doi: 10.1016/j.accpm.2021.100957 |
|
2021 Journal Article Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsisBillot, Laurent, Lipman, Jeffrey, Brett, Stephen J., Waele, Jan J. De, Cotta, Menino Osbert, Davis, Joshua S., Finfer, Simon, Hammond, Naomi E., Knowles, Serena, McGuinness, Shay, Myburgh, John, Paterson, David L., Peake, Sandra, Rajbhandari, Dorrilyn, Rhodes, Andrew, Roger, Claire, Roberts, Jason A., Shirwadkar, Charudatt, Starr, Therese, Taylor, Colman, Dulhunty, Joel M. and For the BLING III Investigators (2021). Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis. Critical Care and Resuscitation, 23 (3), 273-284. doi: 10.51893/2021.3.oa4 |
|
2021 Journal Article Applying antimicrobial pharmacokinetic principles for complex patients: critically ill adult patients receiving extracorporeal membrane oxygenation and renal replacement therapyCheng, Vesa, Abdul-Aziz, Mohd H. and Roberts, Jason A. (2021). Applying antimicrobial pharmacokinetic principles for complex patients: critically ill adult patients receiving extracorporeal membrane oxygenation and renal replacement therapy. Current Infectious Disease Reports, 23 (9) 13. doi: 10.1007/s11908-021-00757-y |
|
2021 Journal Article Pharmacokinetics of fluconazole and ganciclovir as combination antimicrobial chemotherapy on ECMO- A case reportDhanani, Jayesh A., Lipman, Jeffrey, Pincus, Jason, Townsend, Shane, Livermore, Amelia, Wallis, Steven C., Abdul-Aziz, Mohd H. and Roberts, Jason A. (2021). Pharmacokinetics of fluconazole and ganciclovir as combination antimicrobial chemotherapy on ECMO- A case report. International Journal of Antimicrobial Agents, 58 (5) 106431, 106431. doi: 10.1016/j.ijantimicag.2021.106431 |
|
2021 Journal Article Population pharmacokinetics of vancomycin and meropenem in pediatric extracorporeal membrane oxygenation supportZylbersztajn, Brenda, Parker, Suzanne, Navea, Daniel, Izquierdo, Giannina, Ortiz, Paula, Torres, Juan Pablo, Fajardo, Cristian, Diaz, Rodrigo, Valverde, Cristian and Roberts, Jason (2021). Population pharmacokinetics of vancomycin and meropenem in pediatric extracorporeal membrane oxygenation support. Frontiers in Pharmacology, 12 709332, 1-10. doi: 10.3389/fphar.2021.709332 |
|
2021 Journal Article Emerging therapeutic drug monitoring of anti‐infective agents in Australian hospitals: availability, performance and barriers to implementationSandaradura, Indy, Alffenaar, Jan‐Willem, Cotta, Menino O., Daveson, Kathryn, Day, Richard O., Van Hal, Sebastiaan, Lau, Cindy, Marriott, Deborah J. E., Penm, Jonathan, Roberts, Jason A., Tabah, Alexis, Williams, Paul and Imani, Sahand (2021). Emerging therapeutic drug monitoring of anti‐infective agents in Australian hospitals: availability, performance and barriers to implementation. British Journal of Clinical Pharmacology, 88 (2) bcp.14995, 669-679. doi: 10.1111/bcp.14995 |
|
2021 Journal Article Individualized precision dosing approaches to optimize antimicrobial therapy in pediatric populationsTu, Quyen, Cotta, Menino, Raman, Sainath, Graham, Nicolette, Schlapbach, Luregn and Roberts, Jason A (2021). Individualized precision dosing approaches to optimize antimicrobial therapy in pediatric populations. Expert Review of Clinical Pharmacology, 14 (11), 1-17. doi: 10.1080/17512433.2021.1961578 |
|
2021 Journal Article Infrared based saliva screening test for COVID-19Wood, Bayden R., Kochan, Kamila, Bedolla, Diana E., Salazar-Quiroz, Natalia, Grimley, Samantha L., Perez-Guaita, David, Baker, Matthew J., Vongsvivut, Jitraporn, Tobin, Mark J., Bambery, Keith R., Christensen, Dale, Pasricha, Shivani, Eden, Anthony K., Mclean, Aaron, Roy, Supti, Roberts, Jason A., Druce, Julian, Williamson, Deborah A., McAuley, Julie, Catton, Mike, Purcell, Damian F. J., Godfrey, Dale I. and Heraud, Philip (2021). Infrared based saliva screening test for COVID-19. Angewandte Chemie - International Edition, 60 (31), 17102-17107. doi: 10.1002/anie.202104453 |
|
2021 Journal Article Standard of practice in infectious diseases for pharmacy servicesCairns, Kelly A., Avent, Minyon, Buono, Evette, Cheah, Ron, Devchand, Misha, Khumra, Sharmila, Rawlins, Matthew, Roberts, Jason A., Xenos, Kristin and Munro, Courtney (2021). Standard of practice in infectious diseases for pharmacy services. Journal of Pharmacy Practice and Research, 51 (3), 247-264. doi: 10.1002/jppr.1744 |
|
2021 Journal Article Optimising treatment outcomes for children and adults through rapid genome sequencing of sepsis pathogens. A study protocol for a prospective, multi-centre trial (DIRECT)Irwin, Adam D., Coin, Lachlan J. M., Harris, Patrick N. A., Cotta, Menino Osbert, Bauer, Michelle J., Buckley, Cameron, Balch, Ross, Kruger, Peter, Meyer, Jason, Shekar, Kiran, Brady, Kara, Fourie, Cheryl, Sharp, Natalie, Vlad, Luminita, Whiley, David, Beatson, Scott A., Forde, Brian M., Paterson, David, Clark, Julia, Hajkowicz, Krispin, Raman, Sainath, Bialasiewicz, Seweryn, Lipman, Jeffrey, Schlapbach, Luregn J. and Roberts, Jason A. (2021). Optimising treatment outcomes for children and adults through rapid genome sequencing of sepsis pathogens. A study protocol for a prospective, multi-centre trial (DIRECT). Frontiers in Cellular and Infection Microbiology, 11 667680, 1-8. doi: 10.3389/fcimb.2021.667680 |
|
2021 Journal Article Micafungin population PK analysis in plasma and peritoneal fluid in septic patients with intra-abdominal infections: a prospective cohort studyGarbez, Nicolas, Mbatchi, Litaty, Wallis, Steven C., Muller, Laurent, Lipman, Jeffrey, Roberts, Jason A., Lefrant, Jean-Yves and Roger, Claire (2021). Micafungin population PK analysis in plasma and peritoneal fluid in septic patients with intra-abdominal infections: a prospective cohort study. Antimicrobial Agents and Chemotherapy, 65 (7) e02307-20, 1-13. doi: 10.1128/aac.02307-20 |
|
2021 Journal Article Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainmentChiriac, Ute, Frey, Otto R., Roehr, Anka C., Koeberer, Andreas, Gronau, Patrick, Fuchs, Thomas, Roberts, Jason A. and Brinkmann, Alexander (2021). Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainment. Medicine, 100 (22) e26253, 1-7. doi: 10.1097/MD.0000000000026253 |
|
2021 Journal Article Personalized piperacillin dosing for the critically ill: a retrospective analysis of clinical experience with dosing software and therapeutic drug monitoring to optimize antimicrobial dosingChiriac, Ute, Richter, Daniel C., Frey, Otto R., Röhr, Anka C., Helbig, Sophia, Preisenberger, Judit, Hagel, Stefan, Roberts, Jason A., Weigand, Markus A. and Brinkmann, Alexander (2021). Personalized piperacillin dosing for the critically ill: a retrospective analysis of clinical experience with dosing software and therapeutic drug monitoring to optimize antimicrobial dosing. Antibiotics, 10 (6) 667, 667. doi: 10.3390/antibiotics10060667 |
|
2021 Journal Article A systematic review of the clinical pharmacokinetics, pharmacodynamics and toxicodynamics of ganciclovir/valganciclovir in allogeneic haematopoietic stem cell transplant patientsSelby, Philip Roland, Shakib, Sepehr, Peake, Sandra L., Warner, Morgyn S., Yeung, David, Hahn, Uwe and Roberts, Jason A. (2021). A systematic review of the clinical pharmacokinetics, pharmacodynamics and toxicodynamics of ganciclovir/valganciclovir in allogeneic haematopoietic stem cell transplant patients. Clinical Pharmacokinetics, 60 (6), 727-739. doi: 10.1007/s40262-020-00982-z |
|
2021 Journal Article Nebulized colistin in ventilator-associated pneumonia and tracheobronchitis: historical background, pharmacokinetics and perspectivesZhu, Yinggang, Monsel, Antoine, Roberts, Jason A., Pontikis, Konstantinos, Mimoz, Olivier, Rello, Jordi, Qu, Jieming, Rouby, Jean-Jacques, on behalf of the European Investigator Network for Nebulized Antibiotics in Ventilator-Associated Pneumonia (ENAVAP) and Li Bassi, Gianluigi (2021). Nebulized colistin in ventilator-associated pneumonia and tracheobronchitis: historical background, pharmacokinetics and perspectives. Microorganisms, 9 (6) 1154, 1-25. doi: 10.3390/microorganisms9061154 |
|
2021 Journal Article Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill childrenGuerra Valero, Yarmarly C., Dorofaeff, Tavey, Roberts, Jason A., Lipman, Jeffrey, Coulthard, Mark G., Sparkes, Louise, Wallis, Steven C. and Parker, Suzanne L. (2021). Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill children. Analytical and Bioanalytical Chemistry, 413 (17), 4483-4491. doi: 10.1007/s00216-021-03411-7 |
|
2021 Journal Article Microsampling to support pharmacokinetic clinical studies in pediatricsGuerra Valero, Yarmarly, Dorofaeff, Tavey, Parker, Lisa, Coulthard, Mark G., Sparkes, Louise, Lipman, Jeffrey, Wallis, Steven C., Roberts, Jason A. and Parker, Suzanne L. (2021). Microsampling to support pharmacokinetic clinical studies in pediatrics. Pediatric Research, 91 (6), 1-5. doi: 10.1038/s41390-021-01586-4 |
|
2021 Journal Article Pharmacodynamic evaluation of a single dose versus a 24-hour course of multiple doses of cefazolin for surgical prophylaxisHeffernan, Aaron, Alawie, Jowana, Wallis, Steven C., Naicker, Saiyuri, Adiraju, Santosh, Roberts, Jason A. and Sime, Fekade Bruck (2021). Pharmacodynamic evaluation of a single dose versus a 24-hour course of multiple doses of cefazolin for surgical prophylaxis. Antibiotics, 10 (5) 602, 602. doi: 10.3390/antibiotics10050602 |
|
2021 Journal Article Clinical pharmacokinetic and pharmacodynamic considerations in the drug treatment of non-tuberculous mycobacteria in cystic fibrosisBurke, Andrew, Smith, Daniel, Coulter, Chris, Bell, Scott C., Thomson, Rachel and Roberts, Jason A. (2021). Clinical pharmacokinetic and pharmacodynamic considerations in the drug treatment of non-tuberculous mycobacteria in cystic fibrosis. Clinical Pharmacokinetics, 60 (9), 1081-1102. doi: 10.1007/s40262-021-01010-4 |
